“…One of these treatments is cellular therapy with mesenchymal stem cells [4]. MSCs are adherent, fibroblast-like cells that are able to differentiate into diverse cellular lineages and that, in certain microenvironments, can be induced to differentiate into specific lineages [5]. MSCs have been reported to have therapeutic potential in the treatment of kidney disease, especially due to their abilities to promote reno-protective effects, induce proliferation, promote angiogenesis at the affected location, inhibit the inflammatory response, and improve renal function [6,7].…”